Bayesian Capital Management’s Organon & Co OGN Stock Holding History

Bayesian Capital Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-80,600	Closed	-$861K	–	407
2025 Q3	$861K	Buy	+80,600	New	+$791K	0.18%	183
2024 Q4	–	Sell	-11,200	Closed	-$214K	–	896
2024 Q3	$214K	Sell	11,200 -30,800	-73%	-$638K	0.03%	552
2024 Q2	$869K	Buy	42,000 +16,827	+67%	+$334K	0.1%	262
2024 Q1	$473K	Buy	+25,173	New	+$432K	0.05%	451
2022 Q3	–	Sell	-54,415	Closed	-$1.84M	–	931
2022 Q2	$1.84M	Buy	54,415 +2,400	+5%	+$84.1K	0.34%	57
2022 Q1	$1.82M	Buy	+52,015	New	+$1.78M	0.27%	86
2021 Q3	–	Sell	-12,400	Closed	-$375K	–	491
2021 Q2	$375K	Buy	+12,400	New	+$408K	0.1%	228

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

KBG

Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Bayesian Capital Management's OGN Position: Q4 2025 in Review

Bayesian Capital Management sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 80,600 shares — an estimated $861K sold.

Bayesian Capital Management first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $1.84M in Q2 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

Bayesian Capital Management reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 80,600 Organon & Co shares in Q4 2025, an estimated $861K.
Bayesian Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
Bayesian Capital Management's Organon & Co position peaked at $1.84M in Q2 2022.
634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.